This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Cilag International Gmbh. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Sander Cornelis Gerardus Leeuwenburgh: Innovator in Biomedical Applications
Introduction
Sander Cornelis Gerardus Leeuwenburgh is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of biomedical materials through his innovative work on polyoxazoline copolymers. His research focuses on developing materials that can be utilized in various medical applications.
Latest Patents
Leeuwenburgh holds a patent for a polyoxazoline copolymer comprising calcium binding groups. This patent describes copolymers that exhibit a very high affinity for calcium ions, are capable of forming hydrogels, and are bioresorbable. The copolymers consist of at least 20 oxazoline units, including at least 4 non-terminal oxazoline units that contain a calcium binding group. The methods of making these copolymers and their applications in biomedical fields are also detailed in his patent.
Career Highlights
Sander Leeuwenburgh is associated with Cilag International GmbH, where he continues to advance his research and development efforts. His work has the potential to impact various biomedical applications, particularly in the creation of materials that can interact effectively with biological systems.
Collaborations
Leeuwenburgh collaborates with esteemed colleagues such as Joost Opsteen and Johannes Caspar Mathias Elizabeth Bender. Their combined expertise contributes to the innovative research being conducted in the field of biomedical materials.
Conclusion
Sander Cornelis Gerardus Leeuwenburgh is a prominent inventor whose work on polyoxazoline copolymers is paving the way for advancements in biomedical applications. His contributions are significant in the development of materials that can enhance medical treatments and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
